United States · Series A startup

Who invested in LyGenesis

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$3.0Mraised across 1 round since 2018, from 1 source

Latest round
Series A, $3.0MMay 2018
Investors
1
See who backed them

The rounds

  1. May 2018
    Series A$3.0M

    Reported by FinSMEsSEC filing: $2.2M sold, first sale May 2018

Founders and team

From LyGenesis's own website: 3 on the team.

  • Jennifer TaylorDirector, Clinical Operations
  • Jim MellonChairman of the Board of Directors
  • Justin BriggsDirector

Everyone who backed them

JuvenescenceVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists LyGenesis as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Longevity VisionFamily officePer its own site

Quick answers about LyGenesis

Who invested in LyGenesis?

LyGenesis's investors include Juvenescence.

How much has LyGenesis raised?

LyGenesis has raised $3.0M across 1 round since 2018.

When did LyGenesis last raise?

LyGenesis's most recent round was a Series A of $3.0M in May 2018.

What was LyGenesis's biggest round?

Its most recent round, $3.0M in May 2018, is also its largest on record.

Who backed LyGenesis first?

LyGenesis's first round on record, in May 2018, was backed by Juvenescence.

What stage is LyGenesis at?

LyGenesis's latest named round is a Series A, in May 2018.

Where is LyGenesis based?

LyGenesis is based in the United States.

Companies like LyGenesis

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.